Cipros Ltd - Period Ending 2016-09-30
Cipros Ltd - Period Ending 2016-09-30
Registration number:
FINANCIAL PERIOD DATA REFRESH REQUIRED
Select the Refresh button on the Summary or Disclosure tab
Cipros Ltd
for the Year Ended 30 September 2016
Cipros Ltd
Profit and Loss Account for the Year Ended 30 September 2016
The company has not traded during the year. During this year, the company received no income and incurred no expenditure and therefore made neither profit nor loss.
|
Page 1 |
Cipros Ltd
(Registration number: 09204936)
Balance Sheet as at 30 September 2016
|
Note |
2016 |
|
|
Current assets |
||
|
Cash at bank and in hand |
|
|
|
Capital and reserves |
||
|
Called up share capital |
|
|
|
Total equity |
|
For the financial year ending 30 September 2016 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Directors' responsibilities:
|
• |
|
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
Approved and authorised by the
.........................................
Mr David Moodie
Director
.........................................
Mr Stephen Derek Armstrong
Director
.........................................
Mr David Haydn Godfrey
Director
|
Page 2 |
Cipros Ltd
Notes to the Financial Statements for the Year Ended 30 September 2016
|
General information |
Country of incorporation
The address of its registered office is:
These financial statements were authorised for issue by the
|
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.
Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.
|
Cash and cash equivalents |
|
2016 |
|
|
Cash on hand |
|
|
Share capital |
Allotted, called up and fully paid shares
|
Page 3 |
Cipros Ltd
Notes to the Financial Statements for the Year Ended 30 September 2016
|
2016 |
||
|
No. |
£ |
|
|
|
|
3 |
|
Page 4 |
Cipros Ltd
Detailed Profit and Loss Account for the Year Ended 30 September 2016
|
2016 |
|
|
Turnover (analysed below) |
- |
|
Operating profit/(loss) |
- |
|
Profit/(loss) before tax |
- |
|
Page 5 |
Cipros Ltd
Detailed Profit and Loss Account for the Year Ended 30 September 2016
|
2016 |
|
Page 6 |